We designed and synthesized a pyrilamine derivative 1 as a selective class I HDAC inhibitor that targets pyrilamine-sensitive proton-coupled organic cation antiporter (PYSOCA) at the blood-brain barrier (BBB). Introduction of pyrilamine moiety to benzamide type HDAC inhibitors kept selective class I HDAC inhibitory activity and increased BBB permeability. Our BBB transport study showed that compound 1 is a substrate of PYSOCA. Thus, our findings suggest that the hybrid method of HDAC inhibitor and substrate of PYSOCA such as pyrilamine is useful for development of HDAC inhibitors with increased BBB permeability.
Conflict of interest statement
The authors declare no competing financial interest.
Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors.ACS Chem Neurosci. 2014 Jul 16;5(7):588-96. doi: 10.1021/cn500021p. Epub 2014 May 21. ACS Chem Neurosci. 2014. PMID: 24780082 Free PMC article.
Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.Drug Metab Dispos. 2008 Oct;36(10):2005-13. doi: 10.1124/dmd.108.022087. Epub 2008 Jul 7. Drug Metab Dispos. 2008. PMID: 18606742
Pyrilamine-sensitive proton-coupled organic cation (H+/OC) antiporter for brain-specific drug delivery.J Control Release. 2017 May 28;254:34-43. doi: 10.1016/j.jconrel.2017.03.034. Epub 2017 Mar 27. J Control Release. 2017. PMID: 28351667
[Research progress of pyrilamine-sensitive H~+/OC antiporter].Yao Xue Xue Bao. 2016 Jun;51(6):886-91. Yao Xue Xue Bao. 2016. PMID: 29878742 Review. Chinese.
[The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].Yakugaku Zasshi. 2015;135(5):697-702. doi: 10.1248/yakushi.14-00234-2. Yakugaku Zasshi. 2015. PMID: 25948304 Review. Japanese.